CompletedPhase 2NCT00511004
Effect of Albendazole Dose on Treatment of Lymphatic Filariasis
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Thomas B Nutman, M.D., M.DNational Institute of Allergy and Infectious Diseases (NIAID)
- Intervention
- Albendazole(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18-55 years · All sexes
- Timeline
- 2007 – 2014
Study locations (1)
- Filariasis Chemotherapy Unit (FCU), T.D. Medical Hospital, Alleppey, Kerala, India
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00511004 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.